SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Defensive Interval Ratio
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Defensive Interval Ratio of 117 days as of March 2026. Defensive assets of €11.69 Billion (cash €-, short-term investments €2.23 Billion, receivables €9.47 Billion) cover 117 days of daily cash needs of €100.22 Million/day. Check SHANG.FOS.PHARM.GR.H YC 1 (08HH) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SHANG.FOS.PHARM.GR.H YC 1 Defensive Interval Ratio (2021–2025)
This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 117 days, meaning defensive assets of €11.69 Billion can fund 117 days of operations without new revenue. Also explore 08HH shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of SHANG.FOS.PHARM.GR.H YC 1.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 116 days | €11.62 Billion | €99.79 Million/day | €- | €2.25 Billion | ▲ +14 days |
| 2024 | 103 days | €10.55 Billion | €102.61 Million/day | €- | €2.60 Billion | ▼ 0 days |
| 2023 | 103 days | €9.53 Billion | €92.49 Million/day | €- | €1.89 Billion | ▲ +10 days |
| 2022 | 93 days | €8.52 Billion | €91.23 Million/day | €- | €928.53 Million | ▼ -35 days |
| 2021 | 128 days | €10.27 Billion | €80.32 Million/day | €- | €4.24 Billion | — |